JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
about
Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during SpermatogenesisHistone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.Lysine-specific histone demethylases in normal and malignant hematopoiesis.Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.JMJD1C Ensures Mouse Embryonic Stem Cell Self-Renewal and Somatic Cell Reprogramming through Controlling MicroRNA Expression.Deltex2 represses MyoD expression and inhibits myogenic differentiation by acting as a negative regulator of Jmjd1cPlant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.RUNX1-ETO Leukemia.Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.
P2860
Q30252934-20CA16AF-5041-4335-A427-3C10EE3BE82FQ30276495-CA8B5DFD-7E27-4069-B627-D56E10369BB7Q36138616-C7343BCF-3E08-4B50-AB15-333202359B96Q37596831-DD79B938-0F6D-4D61-824E-461D670D7E33Q37679748-7C23C682-9802-47B3-82F6-CF3CDA7FEDD5Q38702343-BB4F0376-8662-4D58-8155-C5CEE43B9791Q38840749-B84BFD07-9BCE-4520-AD22-4BCDEBBAE3E0Q38946185-EC25584F-A9AA-4E1B-B610-1F41E833F987Q41063234-94B3ADEA-28B7-4471-B005-729430A83CBBQ42291306-93FB11A9-2A0C-4AF0-B3DF-4E50B8B0C34DQ45970621-A11EF1B0-1F19-4895-88F8-04CFD149E4CBQ50066248-4EAEA5E2-7926-453E-BA9F-1A8F579418F0Q51097627-9E77B437-3D92-4FD0-B8A3-263E290CDD6FQ55007013-4AFD7EED-C9D2-458A-86ED-5B4331672246
P2860
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
JMJD1C is required for the sur ...... for key transcription factors.
@ast
JMJD1C is required for the sur ...... for key transcription factors.
@en
type
label
JMJD1C is required for the sur ...... for key transcription factors.
@ast
JMJD1C is required for the sur ...... for key transcription factors.
@en
prefLabel
JMJD1C is required for the sur ...... for key transcription factors.
@ast
JMJD1C is required for the sur ...... for key transcription factors.
@en
P2093
P2860
P356
P1433
P1476
JMJD1C is required for the sur ...... for key transcription factors.
@en
P2093
Benoit Laurent
Robert G Roeder
Rowena Eng
Scott A Armstrong
Xiaochuan Liu
Zhanyun Tang
P2860
P304
P356
10.1101/GAD.267278.115
P577
2015-10-01T00:00:00Z